within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AE01_Fingolimod;

model Fingolimod
  extends Pharmacolibrary.Drugs.ATC.L.L04AE01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AE01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fingolimod is an oral sphingosine 1-phosphate receptor modulator approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations and delay disability progression. It is currently widely used for this purpose.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration. Population is both sexes, ages 18-55.</p><h4>References</h4><ol><li><p>Yun, T, et al., &amp; Kang, BT (2023). A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs. <i>In vivo (Athens, Greece)</i> 37(5) 2128–2133. DOI:<a href=&quot;https://doi.org/10.21873/invivo.13309&quot;>10.21873/invivo.13309</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37652477/&quot;>https://pubmed.ncbi.nlm.nih.gov/37652477</a></p></li><li><p>David, OJ, et al., &amp; Schmouder, RL (2012). Clinical pharmacokinetics of fingolimod. <i>Clinical pharmacokinetics</i> 51(1) 15–28. DOI:<a href=&quot;https://doi.org/10.2165/11596550-000000000-00000&quot;>10.2165/11596550-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22149256/&quot;>https://pubmed.ncbi.nlm.nih.gov/22149256</a></p></li><li><p>Kovarik, JM, et al., &amp; Schmouder, RL (2007). Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects. <i>Biopharmaceutics &amp; drug disposition</i> 28(2) 97–104. DOI:<a href=&quot;https://doi.org/10.1002/bdd.535&quot;>10.1002/bdd.535</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17230596/&quot;>https://pubmed.ncbi.nlm.nih.gov/17230596</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fingolimod;
